Organon & Co. Forecast, price target & analysts
Organon & Co. Target price 2026 - Analyst rating & recommendation
Organon & Co. Classifications & Recommendation
Organon & Co. Price Target
| Target Price | $11.73 |
| Price | $13.69 |
| Deviation |
14.32%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Organon & Co. 2027 .
The average Organon & Co. target price is $11.73.
This is
14.32%
register free of charge
$14.70
7.38%
register free of charge
$8.08
40.98%
register free of charge
|
|
| A rating was issued by 13 analysts: 0 Analysts recommend Organon & Co. to buy, 7 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Organon & Co. stock has an average upside potential 2027 of
14.32%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 6.22 | 6.21 |
| 2.92% | 0.08% | |
| EBITDA Margin | 27.45% | 30.17% |
| 0.88% | 9.93% | |
| Net Margin | 3.01% | 14.60% |
| 77.71% | 385.31% |
9 Analysts have issued a sales forecast Organon & Co. 2026 . The average Organon & Co. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Organon & Co. EBITDA forecast 2026. The average Organon & Co. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Organon & Co. Analysts have issued a net profit forecast 2026. The average Organon & Co. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.72 | 3.45 |
| 78.38% | 379.17% | |
| P/E | 3.96 | |
| EV/Sales | 1.77 |
8 Analysts have issued a Organon & Co. forecast for earnings per share. The average Organon & Co. EPS is
This results in the following potential growth metrics and future valuations:
Current Organon & Co. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BNP Paribas |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 28 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 24 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BNP Paribas:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 28 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 24 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 15 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
